Stem Cell Reviews and Reports

, Volume 8, Issue 3, pp 963–971

Effects of Preoperative Short Term Use of Atorvastatin on Endothelial Progenitor Cells after Coronary Surgery: A Randomized, Controlled Trial

  • Çağdaş Baran
  • Serkan Durdu
  • Klara Dalva
  • Çagın Zaim
  • Arın Dogan
  • Gokhan Ocakoglu
  • Günhan Gürman
  • Önder Arslan
  • Ahmet Rüçhan Akar
Article

DOI: 10.1007/s12015-011-9321-z

Cite this article as:
Baran, Ç., Durdu, S., Dalva, K. et al. Stem Cell Rev and Rep (2012) 8: 963. doi:10.1007/s12015-011-9321-z

Abstract

Objectives

We investigated the effects of short-term use of atorvastatin on CD34+/VEGF-R2+/CD133+/CD45- endothelial progenitor cell (EPC) count after on-pump coronary artery bypass surgery (CABG).

Methods

Between Feb-2010 and May-2010, we randomly assigned, in a placebo-controlled, double-blind study, 60 consecutive patients who underwent isolated, first-time CABG to receive either 14-day atorvastatin (40 mg/day) or placebo preoperatively. Urgent CABG and recent myocardial infarction were excluded. EPCs were quantified (cells/μl) by flow cytometric phenotyping obtained from venous blood samples collected preoperatively (T1), 6-hours (T2), and on the 5th day postoperatively (T3). Levels of markers of inflammation and serum cardiac troponin I were also measured preoperatively and daily until day-5 after surgery.

Results

There were no differences in baseline risk factors including cholesterol profiles, and EuroSCORES between the groups. The composite primary end-point, favored statin group with higher amount of circulating, early EPC count (cells/μl) at all time points compared with placebo (T1, 2.30 ± 0.02 versus 1.58 ± 0.03, p < 0.001; T2, 5.00 ± 0.06 versus 2.19 ± 0.06, p < 0.001; T3, 3.03 ± 0.08 versus 1.78 ± 0.02, p < 0.001). Postoperative hsCRP rise were inversely correlated with EPC count, and were significantly lower in the statin group (T1, 0.8 ± 0.1 versus 2.2 ± 1.5, p < 0.001; T2, 72.9 ± 3.2 versus 96.0 ± 3.6, p < 0.001; T3, 4.3 ± 1.2 versus 11.4 ± 4.1, p < 0.001). Furthermore, the incidence of postoperative atrial fibrillation was significantly lower in the statin group compared to placebo (3.3% versus 23%, p = 0.02).

Conclusions

Short-term atorvastatin use increases circulating early EPCs both pre- and post-operatively and is associated with better preservation of sinus rhythm and reduced hsCRP levels. (ClinicalTrials.gov number, NCT01096875)

Keywords

Endothelial progenitor cellsStatinsCABGC-reactive proteinCardiopulmonary bypass

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Çağdaş Baran
    • 1
  • Serkan Durdu
    • 1
    • 2
  • Klara Dalva
    • 3
  • Çagın Zaim
    • 1
  • Arın Dogan
    • 1
    • 4
  • Gokhan Ocakoglu
    • 5
  • Günhan Gürman
    • 2
    • 3
  • Önder Arslan
    • 2
    • 3
  • Ahmet Rüçhan Akar
    • 1
    • 2
  1. 1.Department of Cardiovascular Surgery, Heart CenterAnkara University School of MedicineAnkaraTurkey
  2. 2.Stem Cell InstituteAnkara UniversityAnkaraTurkey
  3. 3.Department of HematologyAnkara University School of MedicineAnkaraTurkey
  4. 4.Biotechnology InstituteAnkara UniversityAnkaraTurkey
  5. 5.Department of BiostatisticsUludag University School of MedicineBursaTurkey